SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (319)11/2/2005 9:00:45 AM
From: Icebrg  Read Replies (1) | Respond to of 362
 
I think Allen is more than anything else into Iloperidone. If he sees something this something might an indication, that Vanda really is able to identify, which patients who will suffer the cardiac side-effects. If that is indeed the fact, the door will be wide open for the drug.

I believe it is some old colleagues of his, who are running Vanda.

Erik


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News